These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3710068)

  • 1. Differing effects of nor-ursodeoxycholic or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit.
    Cohen BI; Hofmann AF; Mosbach EH; Stenger RJ; Rothschild MA; Hagey LR; Yoon YB
    Gastroenterology; 1986 Jul; 91(1):189-97. PubMed ID: 3710068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity of bile acids in rabbits: ursodeoxycholic acid is less toxic than chenodeoxycholic acid.
    Miyai K; Javitt NB; Gochman N; Jones HM; Baker D
    Lab Invest; 1982 Apr; 46(4):428-37. PubMed ID: 7200166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of ursodeoxycholate hepatotoxicity in the rabbit by conjugation with N-methyl amino acids.
    Schmassmann A; Hofmann AF; Angellotti MA; Ton-Nu HT; Schteingart CD; Clerici C; Rossi SS; Rothschild MA; Cohen BI; Stenger RJ
    Hepatology; 1990 Jun; 11(6):989-96. PubMed ID: 2365296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents.
    Yoon YB; Hagey LR; Hofmann AF; Gurantz D; Michelotti EL; Steinbach JH
    Gastroenterology; 1986 Apr; 90(4):837-52. PubMed ID: 3949115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sodium ursodeoxycholate, hyodeoxycholate and dehydrocholate on cholesterol and bile acid metabolism in rats.
    Uchida K; Nomura Y; Kadowaki M; Arisue K; Takeuchi N; Ishikawa Y
    J Pharmacobiodyn; 1983 May; 6(5):346-57. PubMed ID: 6620121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Na+/H+ exchange in the rat is associated with decreased ursodeoxycholate hypercholeresis, decreased secretion of unconjugated urodeoxycholate, and increased ursodeoxycholate glucuronidation.
    Lake JR; Renner EL; Scharschmidt BF; Cragoe EJ; Hagey LR; Lambert KJ; Gurantz D; Hofmann AF
    Gastroenterology; 1988 Aug; 95(2):454-63. PubMed ID: 2455672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ursodeoxycholate dose-dependent formation of ursodeoxycholate-glucuronide in the rat and the choleretic potencies.
    Takikawa H; Sano N; Narita T; Yamanaka M
    Hepatology; 1990 May; 11(5):743-9. PubMed ID: 2347548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis.
    Setchell KD; Rodrigues CM; Podda M; Crosignani A
    Gut; 1996 Mar; 38(3):439-46. PubMed ID: 8675100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria.
    Krähenbühl S; Fischer S; Talos C; Reichen J
    Hepatology; 1994 Dec; 20(6):1595-601. PubMed ID: 7982660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tauroursodeoxycholate increases rat liver ursodeoxycholate levels and limits lithocholate formation better than ursodeoxycholate.
    Rodrigues CM; Kren BT; Steer CJ; Setchell KD
    Gastroenterology; 1995 Aug; 109(2):564-72. PubMed ID: 7615207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.
    Nakagawa M; Colombo C; Setchell KD
    Hepatology; 1990 Aug; 12(2):322-34. PubMed ID: 2391071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport, metabolism, and effect of chronic feeding of lagodeoxycholic acid. A new, natural bile acid.
    Schmassmann A; Angellotti MA; Clerici C; Hofmann AF; Ton-Nu HT; Schteingart CD; Marcus SN; Hagey LR; Rossi SS; Aigner A
    Gastroenterology; 1990 Oct; 99(4):1092-104. PubMed ID: 2394330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The choleretic effects of N-acetylglucosaminides, major urinary metabolites of ursodeoxycholic acid, in bile fistula rats.
    Iwaki T; Hirabayashi N; Miyazawa N; Takeuchi Y; Ishizaki K; Sakakura H; Kasai H; Maeda M; Araki T
    Eur J Pharmacol; 1998 Dec; 363(1):41-8. PubMed ID: 9877080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic biotransformation and choleretic effect of 7-ketolithocholic acid in the rat.
    Kanai S; Sato Y; Nokubo M; Kitani K
    Lipids; 1989 Oct; 24(10):859-65. PubMed ID: 2811609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual trihydroxy bile acids in the urine of patients treated with chenodeoxycholate, ursodeoxycholate or rifampicin and those with cirrhosis.
    Nakashima T; Sano A; Seto Y; Nakajima T; Shima T; Sakamoto Y; Okuno T; Kashima K; Hasegawa T
    Hepatology; 1990 Feb; 11(2):255-60. PubMed ID: 2307404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of ursodeoxycholic acid, an enterohepatic drug.
    Hofmann AF
    Scand J Gastroenterol Suppl; 1994; 204():1-15. PubMed ID: 7824870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid, 7-ketolithocholic acid, and chenodeoxycholic acid are primary bile acids of the nutria (Myocastor coypus).
    Tint GS; Bullock J; Batta AK; Shefer S; Salen G
    Gastroenterology; 1986 Mar; 90(3):702-9. PubMed ID: 3943698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The site-specific delivery of ursodeoxycholic acid to the rat colon by sulfate conjugation.
    Rodrigues CM; Kren BT; Steer CJ; Setchell KD
    Gastroenterology; 1995 Dec; 109(6):1835-44. PubMed ID: 7498648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of ursodeoxycholic acid on biliary bile acid composition in patients with cholesterol gallstone.
    Kanazawa Y; Koizumi M; Hirakawa H; Endo K; Yoshida S; Miyakawa T; Konno Y; Goto Y; Goto J; Nambara T
    Tohoku J Exp Med; 1982 Mar; 136(3):235-49. PubMed ID: 7071843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugation is rate limiting in hepatic transport of ursodeoxycholate in the rat.
    Zouboulis-Vafiadis I; Dumont M; Erlinger S
    Am J Physiol; 1982 Sep; 243(3):G208-13. PubMed ID: 7114264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.